🇺🇸 FDA
Patent

US 11660335

Vaccines against coronavirus and methods of use

granted A61KA61K2039/53A61K2039/54

Quick answer

US patent 11660335 (Vaccines against coronavirus and methods of use) held by Inovio Pharmaceuticals, Inc. expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/53, A61K2039/54, A61K2039/545, A61K2039/572